What is Vir Biotechnology, Inc.'s price / sales?

Vir Biotechnology, Inc. (VIR) reported price / sales of 21.9× in Q1 2026.

How has Vir Biotechnology, Inc.'s price / sales changed year-over-year?

Vir Biotechnology, Inc.'s price / sales decreased by 48.7% year-over-year, from 42.6× to 21.9×.

What is the long-term trend for Vir Biotechnology, Inc.'s price / sales?

Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s price / sales has grown at a -23.2% compound annual growth rate (CAGR), from 45.9× to 12.2×.

What does price / sales mean?

Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.

Vir Biotechnology, Inc. VIR Price / sales

Price / sales at other companies

AmgenAMGN

5.1×+0.2×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

Gilead SciencesGILD

5.8×+1.0×

Viridian Therapeutics, Inc.VRDN

28.2×-3,609×

Iovance Biotherapeutics, Inc.IOVA

5.1×-0.1×

Nuvation BioNUVB

10.4×-44.0×

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.71B+61.1%

Enterprise value$1.53B+102%

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Calculated from Vir Biotechnology, Inc.’s reported figures.

market cap/total revenue=21.9×

Based on the most recent quarter.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s price / sales?: Vir Biotechnology, Inc. (VIR) reported price / sales of 21.9× in Q1 2026.
How has Vir Biotechnology, Inc.'s price / sales changed year-over-year?: Vir Biotechnology, Inc.'s price / sales decreased by 48.7% year-over-year, from 42.6× to 21.9×.
What is the long-term trend for Vir Biotechnology, Inc.'s price / sales?: Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s price / sales has grown at a -23.2% compound annual growth rate (CAGR), from 45.9× to 12.2×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.